FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jørgen Ingerslev

Research Profile

Disorders

Chemicals & Drugs

Physiology

Procedures

Thrombelastography

Living Beings

Infants

Co-author Network

Publications

TOP 3
M S Jensen; O H Larsen; K Christiansen; C Fenger-Eriksen; Jørgen Ingerslev; B Sørensen
Platelet activation and aggregation: the importance of thrombin activity-A laboratory model.
Mariasanta Napolitano; Jean-François Schved; Lisa Michaels; Carmen Altisent; Günter Auerswald; Jens Bjerre; Umran Caliskan; Pimlak Charoenkwan; Ampaiwan Chuansumrit; Giovanni Di Minno; Alberto Dolce; Muriel Giansily-Blaizot; Jørgen Ingerslev; Guglielmo Mariani
Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).
Guglielmo Mariani; Mariasanta Napolitano; Rosario Pérez Garrido; Helen Platokouki; Arlette Ruiz-Saez; Jean F Schved; Benny Sørensen; Guenter Auerswald; Angelika Batorova; Anne-Marie Bertrand; Jens Bjerre; Giovanni Di Minno; Alberto Dolce; Jørgen Ingerslev; Mehran Karimi
Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jørgen Ingerslev (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: M S Jensen; O H Larsen; K Christiansen; C Fenger-Eriksen; Jørgen Ingerslev; B Sørensen
Platelet activation and aggregation: the importance of thrombin activity-A laboratory model.
Haemophilia : the official journal of the World Federation of Hemophilia 2013;19(3):403-8.
2013: Mariasanta Napolitano; Jean-François Schved; Lisa Michaels; Carmen Altisent; Günter Auerswald; Jens Bjerre; Umran Caliskan; Pimlak Charoenkwan; Ampaiwan Chuansumrit; Giovanni Di Minno; Alberto Dolce; Muriel Giansily-Blaizot; Jørgen Ingerslev; Guglielmo Mariani
Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).
Haematologica 2013;98(4):538-44.
2013: Guglielmo Mariani; Mariasanta Napolitano; Rosario Pérez Garrido; Helen Platokouki; Arlette Ruiz-Saez; Jean F Schved; Benny Sørensen; Guenter Auerswald; Angelika Batorova; Anne-Marie Bertrand; Jens Bjerre; Giovanni Di Minno; Alberto Dolce; Jørgen Ingerslev; Mehran Karimi
Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
Thrombosis and haemostasis 2013;109(2):238-47.
2013: Ole H Larsen; Deepti Radia; Jørgen Ingerslev; Jesper Stentoft; Benny Sørensen
Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.
British journal of haematology 2013;160(2):228-36.
2012: Ole H Larsen; Christian Fenger-Eriksen; Jørgen Ingerslev; Benny Sørensen
Improved point-of-care identification of hyperfibrinolysis is needed.
Thrombosis research 2012;130(4):690-1.
2012: Guglielmo Mariani; Mariasanta Napolitano; A Tagliaferri; Guenter Auerswald; Angelika Batorova; A R De Saez; M D Di Minno; Alberto Dolce; M Giansily-Blaizot; Jørgen Ingerslev
Invasive procedures and minor surgery in factor VII deficiency.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(3):e63-5.
2012: B Sørensen; Jørgen Ingerslev
Dynamic APTT parameters: applications in thrombophilia.
Journal of thrombosis and haemostasis : JTH 2012;10(2):244-50.
2011: Ole Halfdan Larsen; Kirsten Christiansen; Christian Fenger-Eriksen; Jørgen Ingerslev; Benny Sørensen
Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents.
Anesthesiology 2011;115(2):294-302.
2011: Guglielmo Mariani; Alberto Dolce; Angelika Batorova; Günter Auerswald; Jean Francois Schved; Sergio Siragusa; Mariasanta Napolitano; Jens Bjerre Knudsen; Jørgen Ingerslev
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.
British journal of haematology 2011;152(3):340-6.
2010: Christian Fenger-Eriksen; Gary William Moore; Savita Rangarajan; Jørgen Ingerslev; Benny Sørensen
Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders.
Transfusion 2010;50(12):2571-6.
2010: Giancarlo Castaman; Alberto Tosetto; Anne C Goodeve; Augusto B Federici; Stefan Lethagen; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; David Habart; Frank Hill; Ian R Peake; Francesco Rodeghiero
The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
British journal of haematology 2010;151(3):245-51.
2010: R Beyer; Jørgen Ingerslev; B Sørensen
Current practice in the management of muscle haematomas in patients with severe haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16(6):926-31.
2010: R Beyer; Jørgen Ingerslev; B Sørensen
Muscle bleeds in professional athletes--diagnosis, classification, treatment and potential impact in patients with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16(6):858-65.
2010: Benny Sørensen; Christian Fenger-Eriksen; Kirsten Christiansen; Ole H Larsen; Jørgen Ingerslev
Evaluation of coagulation kinetics using thromboelastometry-methodologic influence of activator and test medium.
Annals of hematology 2010;89(11):1155-61.
2010: Giancarlo Castaman; Alberto Tosetto; A Cappelletti; A Goodeve; Augusto B Federici; J Batlle; D Meyer; J Goudemand; J C J Eikenboom; Reinhard Schneppenheim; U Budde; Jørgen Ingerslev; Stefan Lethagen; F Hill; I R Peake; Francesco Rodeghiero
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.
Thrombosis research 2010;126(3):227-31.
2010: Ole H Larsen; Mirella Ezban; Egon Persson; Jørgen Ingerslev; Benny Sørensen
Artificial contact pathway activation masks the haemostatic potential of rFVIIa and NN1731 in thrombocytopenic whole blood.
British journal of haematology 2010;150(1):124-7.
2010: Benny Sørensen; Jørgen Ingerslev
Platelet infusion supports recombinant factor VIIa in a patient with severe haemophilia A and inhibitor--clinical outcome and laboratory observations.
Thrombosis and haemostasis 2010;103(6):1275-6.
2010: S Saulyte Trakymiene; Jørgen Ingerslev; L Rageliene
Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16(3):479-86.
2010: Peter Collins; Francesco Baudo; Angela Huth-Kühne; Jørgen Ingerslev; Craig M Kessler; Maria E Mingot Castellano; Midori Shima; Jean St-Louis; Hervé Lévesque
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A.
BMC research notes 2010;3():161.
2009: C Fenger-Eriksen; Jørgen Ingerslev; Benny Sørensen
Fibrinogen concentrate--a potential universal hemostatic agent.
Expert opinion on biological therapy 2009;9(10):1325-33.
2009: J C J Eikenboom; L Hilbert; A S Ribba; A Hommais; David Habart; S Messenger; A Al-Buhairan; A Guilliatt; W Lester; Claudine Mazurier; Dominique Meyer; Edith Fressinaud; Ulrich Budde; K Will; Reinhard Schneppenheim; T Obser; O Marggraf; E Eckert; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Jenny Goudemand; Jørgen Ingerslev; Stefan Lethagen; Frank Hill; Ian R Peake; Anne C Goodeve
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study.
Journal of thrombosis and haemostasis : JTH 2009;7(8):1304-12.
2009: C Fenger-Eriksen; E Tønnesen; Jørgen Ingerslev; B Sørensen
Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy.
Journal of thrombosis and haemostasis : JTH 2009;7(7):1099-105.
2009: Anne Barklin; Else Tønnesen; Jørgen Ingerslev; Benny Sørensen; Christian Fenger-Eriksen
Coagulopathy during induced severe intracranial hypertension in a porcine donor model.
Anesthesiology 2009;110(6):1287-92.
2009: C Fenger-Eriksen; T M Jensen; B S Kristensen; K M Jensen; E Tønnesen; Jørgen Ingerslev; B Sørensen
Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial.
Journal of thrombosis and haemostasis : JTH 2009;7(5):795-802.
2009: francesco bernardi; Alberto Dolce; Mirko Pinotti; Amy D Shapiro; E Santagostino; F Peyvandi; A Batorova; M Lapecorella; J F Schved; Jørgen Ingerslev; Guglielmo Mariani
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B.
Journal of thrombosis and haemostasis : JTH 2009;7(5):774-9.
2009: Angela Huth-Kühne; Francesco Baudo; Peter Collins; Jørgen Ingerslev; Craig M Kessler; Hervé Lévesque; Maria Eva Mingot Castellano; Midori Shima; Jean St-Louis
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.
Haematologica 2009;94(4):566-75.
2009: C Fenger-Eriksen; E Tønnesen; Jørgen Ingerslev; B Sørensen
Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids.
Acta anaesthesiologica Scandinavica 2009;53(3):332-8.
2009: P L F Giangrande; J T Wilde; B Madan; C A Ludlam; E G D Tuddenham; N J Goddard; G Dolan; Jørgen Ingerslev
Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(2):501-8.
2009: Christian Fenger-Eriksen; Jørgen Ingerslev; Else Tønnesen; Benny Sørensen
Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy.
Annals of hematology 2009;88(3):255-60.
2009: M Tang; P Wierup; K Terp; Jørgen Ingerslev; B Sørensen
Cardiac surgery in patients with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(1):101-7.
2009: A L Poulsen; L H Pedersen; A-M Hvas; L H Poulsen; H Thykjaer; Jørgen Ingerslev
Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(1):285-9.
2009: K L Tefre; Jørgen Ingerslev; B Sørensen
Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(1):281-4.
2009: Anne-Mette Hvas; Jørgen Ingerslev; Jannie Dalby Salvig
Thrombophilia risk factors are associated with intrauterine foetal death and pregnancy-related venous thromboembolism.
Scandinavian journal of clinical and laboratory investigation 2009;69(2):288-94.
2009: Ole H Larsen; Niels Clausen; Egon Persson; Mirella Ezban; Jørgen Ingerslev; Benny Sørensen
Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue.
British journal of haematology 2009;144(1):99-106.
2008: C Fenger-Eriksen; M Lindberg-Larsen; A Q Christensen; Jørgen Ingerslev; Benny Sørensen
Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations.
British journal of anaesthesia 2008;101(6):769-73.
2008: Ruta Tuckuviene; Søren Paaske Johnsen; Jon Helgestad; Jørgen Ingerslev; Søren Risom Kristensen
[Venous thromboembolism in children].
Ugeskrift for laeger 2008;170(43):3424-9.
2008: Edward G D Tuddenham; Jørgen Ingerslev; L Norengaard Sørensen; K Christiansen; G Mariani; Flora Peyvandi; Simon Waddington; S M K Buckley; S Kochanek; M K Chuah; T Vandendriessche; Erik Berntorp
Genetic aspects and research development in haemostasis.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 3():113-8.
2008: Jørgen Ingerslev; B Sørensen; G Castaman; J V Lloyd; J D Varon; N Savion
New approaches in the measurement of coagulation.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 3():104-12.
2008: Guy Young; Liselotte S Ebbesen; Dorthe Viuff; Jorge Di Paola; Barbara A Konkle; Claude Negrier; John Pasi; Jørgen Ingerslev
Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2008;19(4):276-82.
2008: K Ovlisen; A T Kristensen; L A Valentino; N Hakobyan; Jørgen Ingerslev; M Tranholm
Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice.
Journal of thrombosis and haemostasis : JTH 2008;6(6):969-75.
2008: Sandra L Haberichter; Giancarlo Castaman; Ulrich Budde; Ian Peake; Anne Goodeve; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank G H Hill; Robert R Montgomery
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
Blood 2008;111(10):4979-85.
2008: U Budde; R Schneppenheim; J Eikenboom; A Goodeve; K Will; E Drewke; G Castaman; F Rodeghiero; A B Federici; J Batlle; A Pérez; D Meyer; C Mazurier; J Goudemand; Jørgen Ingerslev; D Habart; Z Vorlova; L Holmberg; S Lethagen; J Pasi; F Hill; I Peake
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD).
Journal of thrombosis and haemostasis : JTH 2008;6(5):762-71.
2008: Giancarlo Castaman; Stefan Lethagen; Augusto B Federici; Alberto Tosetto; Anne Goodeve; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Edith Fressinaud; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; John Pasi; Frank Hill; Ian Peake; Francesco Rodeghiero
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
Blood 2008;111(7):3531-9.
2008: B T Colvin; J Astermark; K Fischer; A Gringeri; R Lassila; W Schramm; A Thomas; Jørgen Ingerslev
European principles of haemophilia care.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(2):361-74.
2008: Roberto Musso; Elena Santagostino; Albert Faradji; Alfonso Iorio; Jan van der Meer; Jørgen Ingerslev; Thierry Lambert; Monika Maas-Enriquez; Eduard Gorina
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting.
Thrombosis and haemostasis 2008;99(1):52-8.
2007: A-M Hvas; H T Sørensen; L Norengaard; K Christiansen; Jørgen Ingerslev; Benny Sørensen
Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A.
Journal of thrombosis and haemostasis : JTH 2007;5(12):2408-14.
2007: Søren Tang Knudsen; P Jeppesen; C A Frederiksen; Niels Holmark Andersen; T Bek; Jørgen Ingerslev; Carl E Mogensen; Per Løgstrup Poulsen
Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(8):911-5.
2007: Søren Tang Knudsen; Peter Jeppesen; Christian Alcaraz Frederiksen; Niels Holmark Andersen; Toke Bek; Jørgen Ingerslev; Carl Erik Mogensen; Per Løgstrup Poulsen
Endothelial perturbation: a link between non-dipping and retinopathy in type 2 diabetes?
Journal of the American Society of Hypertension : JASH 2007;1(3):208-15.
2007: Jørgen Ingerslev; T Herlin; B Sørensen; N Clausen; K C Chu; K A High
Severe factor X deficiency in a pair of siblings: clinical presentation, phenotypic and genotypic features, prenatal diagnosis and treatment.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(3):334-6.
2007: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; M Bernardi; K Bertoncello; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
Journal of thrombosis and haemostasis : JTH 2007;5(4):715-21.
2007: Benny Sørensen; Egon Persson; Jørgen Ingerslev
Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.
British journal of haematology 2007;137(2):158-65.
2007: Jørgen Ingerslev
Pharmacovigilance studies in haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(2):121-3.
2007: Ole Halfdan Larsen; Jørgen Ingerslev; Benny Sørensen
Whole blood laboratory model of thrombocytopenia for use in evaluation of hemostatic interventions.
Annals of hematology 2007;86(3):217-21.
2007: Jørgen Ingerslev; T Vanek; S Culic
Use of recombinant factor VIIa for emergency reversal of anticoagulation.
Journal of postgraduate medicine 2007;53(1):17-22.
2007: Anne C Goodeve; J C J Eikenboom; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; David Habart; Zdena Vorlova; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Mohammad Hashemi Soteh; Luciano Baronciani; Christer Hallden; Andrea M Guilliatt; William A Lester; Ian R Peake
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
Blood 2007;109(1):112-21.
2006: Torben Ostergård; Birgit Nyholm; Troels Krarup Hansen; Lars M Rasmussen; Jørgen Ingerslev; Keld E Sørensen; Hans Erik Bøtker; Bengt Saltin; Ole Schmitz
Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training.
Metabolism: clinical and experimental 2006;55(11):1508-15.
2006: Benny Sørensen; Jørgen Ingerslev
A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
Thrombosis and haemostasis 2006;96(4):446-53.
2006: J Evan Sadler; Ulrich Budde; J C J Eikenboom; Emmanuel Favaloro; Frank G H Hill; Lars Holmberg; Jørgen Ingerslev; C A Lee; D Lillicrap; P M Mannucci; Claudine Mazurier; Dominique Meyer; W L Nichols; M Nishino; Ian R Peake; Francesco Rodeghiero; R Schneppenheim; Z M Ruggeri; A Srivastava; R R Montgomery; Augusto B Federici
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.
Journal of thrombosis and haemostasis : JTH 2006;4(10):2103-14.
2006: C Fenger-Eriksen; Jørgen Ingerslev; B Sørensen
Coagulopathy induced by colloid plasma expanders--search for an efficacious haemostatic intervention.
Acta anaesthesiologica Scandinavica 2006;50(7):899-900.
2006: T W Barrowcliffe; Marco Cattaneo; Gian Marco Podda; Paolo Bucciarelli; Federico Lussana; Anna Lecchi; C H Toh; Coenraad Hemker; Suzette Béguin; Jørgen Ingerslev; B Sørensen
New approaches for measuring coagulation.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12 Suppl 3():76-81.
2006: Liselotte Sabroe Ebbesen; Sanne H Olesen; Mogens Kruhøffer; Jørgen Ingerslev; Torben F Ørntoft
Folate deficiency induced hyperhomocysteinemia changes the expression of thrombosis-related genes.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2006;17(4):293-301.
2006: Søren Brandsborg; Benny Sørensen; Lone Hvitfeldt Poulsen; Jørgen Ingerslev
Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2006;17(4):241-9.
2006: J C J Eikenboom; Vincent Van Marion; H Putter; Anne C Goodeve; Francesco Rodeghiero; Giancarlo Castaman; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD.
Journal of thrombosis and haemostasis : JTH 2006;4(4):774-82.
2006: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Edith Fressinaud; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
Journal of thrombosis and haemostasis : JTH 2006;4(4):766-73.
2006: R F Johansen; B Sørensen; Jørgen Ingerslev
Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(2):190-7.
2006: L Hvitfeldt Poulsen; K Christiansen; Benny Sørensen; Jørgen Ingerslev
Whole blood thrombelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients.
Scandinavian journal of clinical and laboratory investigation 2006;66(4):329-36.
2006: Jørgen Ingerslev; Ivan Hvid
Surgery in hemophilia. The general view: patient selection, timing, and preoperative assessment.
Seminars in hematology 2006;43(1 Suppl 1):S23-6.
2006: Guglielmo Mariani; B A Konkle; Jørgen Ingerslev
Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(1):19-27.
2005: Benny Sørensen; Jørgen Ingerslev
Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11 Suppl 1():1-6.
2005: Liselotte Sabroe Ebbesen; Jørgen Ingerslev
Folate deficiency-induced hyperhomocysteinemia attenuates, and folic acid supplementation restores, the functional activities of rat coagulation factors XII, X, and II.
The Journal of nutrition 2005;135(8):1836-40.
2005: K van Dijk; K Fischer; Johanna van der Bom; Elma Scheibel; Jørgen Ingerslev; H Marijke van den Berg
Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands.
British journal of haematology 2005;130(1):107-12.
2005: Jørgen Ingerslev; Benny Sørensen
[Fibrinogen substitution. Use in the treatment of bleeding due to lack of fibrinogen].
Ugeskrift for laeger 2005;167(25-31):2759-61.
2005: Jørgen Ingerslev
[Recombinant activated factor VIIa in massive hemorrhage].
Ugeskrift for laeger 2005;167(25-31):2737.
2005: B Sørensen; C Fenger-Eriksen; Jørgen Ingerslev
Recombinant factor VIIa fails to correct coagulopathy induced by haemodilution with colloid.
British journal of anaesthesia 2005;94(6):862-3.
2005: Jørgen Ingerslev; K Christiansen; Benny Sørensen
Inhibitor to factor VII in severe factor VII deficiency: detection and course of the inhibitory response.
Journal of thrombosis and haemostasis : JTH 2005;3(4):799-800.
2005: Guglielmo Mariani; Falko H Herrmann; Alberto Dolce; Angelika Batorova; Daniela Etro; Flora Peyvandi; Karin Wulff; Jean F Schved; Günter Auerswald; Jørgen Ingerslev; francesco bernardi
Clinical phenotypes and factor VII genotype in congenital factor VII deficiency.
Thrombosis and haemostasis 2005;93(3):481-7.
2005: C Fenger-Eriksen; E Anker-Møller; J Heslop; Jørgen Ingerslev; B Sørensen
Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.
British journal of anaesthesia 2005;94(3):324-9.
2004: Jens Fuglsang; Jørgen Ingerslev; Hanne Havsteen
Recurrent thromboembolism in ovarian cancer.
Acta obstetricia et gynecologica Scandinavica 2004;83(12):1218-20.
2004: Wolf Drescher; Karen P Weigert; Mathias H Bünger; Jørgen Ingerslev; Cody Bünger; Ebbe S Hansen
Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2004;22(3):501-8.
2004: Jørgen Ingerslev
FDA Workshop on factor VIII inhibitors held at the NIH, Bethesda, MA on 21 November 2003.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10(3):288-9.
2004: Jørgen Ingerslev; Michael A Jankowski; S B Weston; L A Charles
Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays.
Journal of thrombosis and haemostasis : JTH 2004;2(4):623-8.
2004: Jørgen Ingerslev; L Hvitfeldt Poulsen; Benny Sørensen
Current treatment of von Willebrand's disease.
Hämostaseologie 2004;24(1):56-64.
2004: Benny Sørensen; Jørgen Ingerslev
Thromboelastography and recombinant factor VIIa-hemophilia and beyond.
Seminars in hematology 2004;41(1 Suppl 1):140-4.
2004: Benny Sørensen; Jørgen Ingerslev
Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
Journal of thrombosis and haemostasis : JTH 2004;2(1):102-10.
2003: Guglielmo Mariani; Falko H Herrmann; S Schulman; Angelika Batorova; Karin Wulff; Daniela Etro; A Dolce; Guenter Auerswald; J Astermark; J-F Schved; Jørgen Ingerslev; francesco bernardi
Thrombosis in inherited factor VII deficiency.
Journal of thrombosis and haemostasis : JTH 2003;1(10):2153-8.
2003: Benny Sørensen; Peter Johansen; Gitte L Nielsen; Jens C Sørensen; Jørgen Ingerslev
Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):469-77.
2003: Liselotte Sabroe Ebbesen; Kirsten Christiansen; Jørgen Ingerslev
Hyperhomocysteinemia due to folate deficiency is thrombogenic in rats.
The Journal of nutrition 2003;133(7):2250-5.
2003: Jørgen Ingerslev; L H Poulsen; Benny Sørensen
Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9(4):348-52.
2003: Benny Sørensen; P Johansen; K Christiansen; M Woelke; Jørgen Ingerslev
Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation.
Journal of thrombosis and haemostasis : JTH 2003;1(3):551-8.
2003: Astrid K N Iversen; Claus Bohn Christiansen; Jørn Attermann; Jesper Eugen-Olsen; Sam Schulman; Erik Berntorp; Jørgen Ingerslev; Lars Fugger; Elma Scheibel; Lilian Tengborn; Jan Gerstoft; Ebbe Dickmeiss; Arne Svejgaard; Peter Skinhøj
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.
The Journal of infectious diseases 2003;187(2):215-25.
2002: CH Foss; E Vestbo; A Frøland; Jørgen Ingerslev; HJ Gjessing; Carl E Mogensen; EM Damsgaard
Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects.
Journal of internal medicine 2002;252(2):155-63.
2002: Wolf Drescher; Haisheng Li; Søren D Jensen; Jørgen Ingerslev; Ebbe S Hansen; Ellen M Hauge; Cody Bünger
The effect of long-term methylprednisolone treatment on the femoral head in growing pigs.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2002;20(4):662-8.
2002: Kenneth N Maclean; Mette Gaustadnes; Jana Oliveriusová; Miroslav Janosík; Eva Kraus; Viktor Kozich; Vladimir Kery; Flemming Skovby; Niels Rüdiger; Jørgen Ingerslev; Sally P Stabler; Robert H Allen; Jan P Kraus
High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations.
Human mutation 2002;19(6):641-55.
2002: T W Barrowcliffe; K Mertens; F E Preston; Jørgen Ingerslev
Laboratory aspects of haemophilia therapy.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(3):244-9.
2002: Jørgen Ingerslev; Kirsten Christiansen; Hanne B Ravn; Gordon L Bray; Edward D Gomperts
Antibodies to heterologous proteins in hemophilia A patients receiving recombinant factor VIII (Recombinate).
Thrombosis and haemostasis 2002;87(4):626-34.
2002: Sixtus Thorsen; Jørgen Ingerslev
[Suspected von Willebrand disease--how to proceed?].
Ugeskrift for laeger 2002;164(6):783.
2001: Birgitte Klug Albertsen; Henrik Schrøder; Jørgen Ingerslev; Preben Jakobsen; Vassilios I Avramis; Hans-Joachim Müller; Niels T Carlsen; Kjeld Schmiegelow
Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
British journal of haematology 2001;115(4):983-90.
2001: M C Poon; R d'Oiron; I Hann; C Négrier; L de Lumley; A Thomas; A Karafoulidou; C Demers; A Street; A Huth-Kühne; P Petrini; E Fressinaud; M Morfini; L Tengborn; A Marquès-Verdier; R Musso; O Devecioglu; D S Houston; S Lethagen; C Van Geet; M von Depka; C Berger; P Beurrier; H A Britton; W Gerrits; C Guthner; S Kuhle; J J Lorenzo; P E Makris; N Nohe; P Paugy; B Pautard; M F Torchet; N Trillot; M Vicariot; J Wilde; M Winter; H Chambost; Jørgen Ingerslev; M Peters; G Strauss
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
Seminars in hematology 2001;38(4 Suppl 12):21-5.
2001: A P Schroeder; L L Knudsen; S E Husted; L Knudsen; Jørgen Ingerslev
Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.
Journal of thrombosis and thrombolysis 2001;12(2):157-63.
2001: E Ejlersen; T Melsen; Jørgen Ingerslev; RB Andreasen; H Vilstrup
Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices.
Scandinavian journal of gastroenterology 2001;36(10):1081-5.
2001: Uri Martinowitz; Gili Kenet; E Segal; Jacob Luboshitz; Aharon Lubetsky; Jørgen Ingerslev; Mauricio Lynn
Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
The Journal of trauma 2001;51(3):431-8; discussion 438-9.
2001: EV Stenbøg; D A Steinbrüchel; A B Thomsen; Ulrik Baandrup; L Heickendorff; Jørgen Ingerslev; N T Andersen; Kristian Emmertsen
The pulmonary vasculature in a neonatal porcine model with increased pulmonary blood flow and pressure.
Cardiology in the young 2001;11(4):420-30.
2001: B Sørensen; G L Nielsen; Liselotte Sabroe Ebbesen; Jørgen Ingerslev
Feasibility of LMW heparin prophylaxis for management of thrombophilia investigation in patients on oral anticoagulation therapy.
Thrombosis and haemostasis 2001;85(3):563-4.
2001: Gilbert C White; F Rosendaal; Louis M Aledort; Jeanne M Lusher; Chantal Rothschild; Jørgen Ingerslev
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
Thrombosis and haemostasis 2001;85(3):560.
2000: U S Niklassen; Jørgen Ingerslev; N H Birkebaek
[Hereditary antithrombin deficiency resulting in severe neonatal thrombosis].
Ugeskrift for laeger 2000;162(45):6081-2.
2000: Henrik Krarup; J M Møller; Peer B Christensen; T Fuglsang; Jørgen Ingerslev; T Arnfred; PH Madsen
Haemophilic patients with hepatitis C have higher viral load compared to other well-defined patient groups.
Journal of viral hepatitis 2000;7(6):435-9.
2000: Jørgen Ingerslev
Hemophilia. Strategies for the treatment of inhibitor patients.
Haematologica 2000;85(10 Suppl):15-20.
2000: L Hansen; H L Kristensen; T Bek; Jørgen Ingerslev
Markers of thrombophilia in retinal vein thrombosis.
Acta ophthalmologica Scandinavica 2000;78(5):523-6.
2000: S Allen; AM Abuzenadah; JL Hinks; JL Blagg; T Gursel; Jørgen Ingerslev; Anne C Goodeve; Ian R Peake; Martina E Daly
A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion.
Blood 2000;96(2):560-8.
2000: Guglielmo Mariani; Falko H Herrmann; francesco bernardi; J F Schved; Guenter Auerswald; Jørgen Ingerslev
Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)
Blood 2000;96(1):374.
2000: Rainer Schwaab; Johannes Oldenburg; G Kemball-Cook; Thilo Albert; C Juhler; Peter Hanfland; Jørgen Ingerslev
Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family.
British journal of haematology 2000;109(3):523-8.
2000: Mette Gaustadnes; Niels Rüdiger; K Rasmussen; Jørgen Ingerslev
Familial thrombophilia associated with homozygosity for the cystathionine beta-synthase 833T-->C mutation.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(5):1392-5.
2000: Jørgen Ingerslev; K Christiansen; A Calatzis; M Holm; L Sabroe Ebbesen
Management and monitoring of recombinant activated factor VII.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11 Suppl 1():S25-30.
2000: Mette Gaustadnes; Niels Rüdiger; K Rasmussen; Jørgen Ingerslev
Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
Thrombosis and haemostasis 2000;83(4):554-8.
2000: S Allen; AM Abuzenadah; JL Blagg; JL Hinks; IM Nesbitt; Anne C Goodeve; T Gursel; Jørgen Ingerslev; Ian R Peake; Martina E Daly
Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor.
Blood 2000;95(6):2000-7.
2000: H E Bøtker; Jørgen Ingerslev
Plasma concentrations of von Willebrand factor in patients with angina pectoris secondary to coronary atherosclerosis or cardiac syndrome X.
Thrombosis research 2000;97(6):519-23.
2000: Karen Helene Orstavik; Elma Scheibel; Jørgen Ingerslev; M Schwartz
Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
Thrombosis and haemostasis 2000;83(3):433-7.
2000: Jørgen Ingerslev
Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.
Seminars in thrombosis and hemostasis 2000;26(4):425-32.
2000: CP Engelfriet; Henk W Reesink; P M Mannucci; Alessandro Gringeri; Jørgen Ingerslev; D B Brettler; Eveline P Mauser-Bunschoten; Claude Negrier; E Berntorp; O P Smith; Amy D Shapiro
The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
Vox sanguinis 2000;78(4):256-61.
1999: Jørgen Ingerslev
Thrombophilia: a feature of importance in retinal vein thrombosis?
Acta ophthalmologica Scandinavica 1999;77(6):619-21.
1999: M Holm; RB Andreasen; Jørgen Ingerslev
Management of bleeding using recombinant factor VIIa in a patient suffering from bleeding tendency due to a lupus anticoagulant-hypoprothrombinemia syndrome.
Thrombosis and haemostasis 1999;82(6):1776-8.
1999: C Thomsen; O Rasmussen; C Christiansen; Eva Pedersen; M Vesterlund; H Storm; Jørgen Ingerslev; Kjeld Hermansen
Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects.
European journal of clinical nutrition 1999;53(10):818-23.
1999: Mette Gaustadnes; Niels Rüdiger; J Møller; K Rasmussen; T Bjerregaard Larsen; Jørgen Ingerslev
Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(5):251-9.
1999: Mette Gaustadnes; Jørgen Ingerslev; N Rütiger
Prevalence of congenital homocystinuria in Denmark.
The New England journal of medicine 1999;340(19):1513.
1999: I Hvid; Jørgen Ingerslev
[Is intravascular coagulation the cause of Legg-Calve-Perthes disease?].
Ugeskrift for laeger 1999;161(19):2819.
1999: Gilbert C White; Donna DiMichele; K Mertens; Claude Negrier; I R Peake; C Prowse; R Schwaab; A Yoshioka; Jørgen Ingerslev
Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Thrombosis and haemostasis 1999;81(3):462.
1999: Jørgen Ingerslev; O Sneppen; I Hvid; U Fredberg; H L Kristensen; S Sindet-Petersen
Treatment of acute bleeding episodes with rFVIIa.
Vox sanguinis 1999;77 Suppl 1():42-6.
1999: S Nielsen; A Schmitz; T Bacher; Michael Rehling; Jørgen Ingerslev; C E Mogensen
Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin.
Diabetologia 1999;42(1):60-7.
1998: Ulrich Vischer; Jef J Emeis; H J Bilo; Coen D A Stehouwer; C Thomsen; O Rasmussen; K Hermansen; C B Wollheim; Jørgen Ingerslev
von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
Thrombosis and haemostasis 1998;80(6):1002-7.
1998: Mette Gaustadnes; Niels Rüdiger; Jørgen Ingerslev
The 20210 A allele of the prothrombin gene is not a risk factor for juvenile stroke in the Danish population.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(7):663-4.
1998: O K Jensen; Jørgen Ingerslev
[Increased p-homocysteine--a risk factor for thrombosis].
Ugeskrift for laeger 1998;160(30):4405-10.
1998: Mette Gaustadnes; Leo A J Kluijtmans; O K Jensen; K Rasmussen; Sandra G Heil; Jan P Kraus; H J Blom; Jørgen Ingerslev; Niels Rüdiger
Detection of a novel deletion in the cystathionine beta-synthase (CBS) gene using an improved genomic DNA based method.
FEBS letters 1998;431(2):175-9.
1998: Jørgen Ingerslev; H L Kristensen
Clinical picture and treatment strategies in factor VII deficiency.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(4):689-96.
1998: U Hedner; Jørgen Ingerslev
Clinical use of recombinant FVIIa (rFVIIa).
Transfusion science 1998;19(2):163-76.
1998: Claude Négrier; C Menart; O Attali; PY Petit; Anne Lienhart; Marc Dechavanne; Jørgen Ingerslev
Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9 Suppl 1():S135-41.
1998: Jørgen Ingerslev; M Holm; K Christiansen; L Knudsen; C Négrier
Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9 Suppl 1():S129-34.
1998: Jørgen Ingerslev; H Thykjaer; O Kudsk Jensen; U Fredberg
Home treatment with recombinant activated factor VII: results from one centre.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9 Suppl 1():S107-10.
1998: Jeanne M Lusher; Jørgen Ingerslev; Harold R Roberts; U Hedner
Clinical experience with recombinant factor VIIa.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(2):119-28.
1998: Alex Lund Laursen; Jørgen Ingerslev; Paul L Andersen; Lars Ostergaard
Viremia in chronic hepatitis C patients evaluated by the Amplicor RT-PCR, a nested RT-PCR, and transaminase levels.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1998;106(2):334-8.
1998: Jørgen Ingerslev; H Thykjaer; Elma Scheibel
Approaches towards successful home treatment in patients with inhibitors.
European journal of haematology. Supplementum 1998;63():11-4.
1998: Alex Lund Laursen; Elma Scheibel; Jørgen Ingerslev; Niels Clausen; Per S Wantzin; Lars Ostergaard; G Schou; F T Black; Kim Krogsgaard
Alpha interferon therapy in Danish haemophiliac patients with chronic hepatitis C: results of a randomized controlled open label study comparing two different maintenance regimens following standard interferon-alpha-2b treatment.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(1):25-32.
1997: Ulrich Vischer; Jørgen Ingerslev; CB Wollheim; JC Mestries; D A Tsakiris; W E Haefeli; Egbert Kruithof
Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.
Thrombosis and haemostasis 1997;77(2):387-93.
1997: H B Rahr; C Roman; Jørgen Ingerslev; J Jørgensen
Markers of haemostatic activation before and after blood donation and plasmapheresis.
Vox sanguinis 1997;73(1):12-5.
1996: Sven Erik Nørholt; Steen Sindet-Pedersen; U Larsen; U Bang; Jørgen Ingerslev; O Nielsen; H J Hansen; A K Ersbøll
Pain control after dental surgery: a double-blind, randomised trial of lornoxicam versus morphine.
Pain 1996;67(2-3):335-43.
1996: B D Andersen; B Lind; M Philips; A B Hansen; Jørgen Ingerslev; Sixtus Thorsen
Two mutations in exon XII of the protein S alpha gene in four thrombophilic families resulting in premature stop codons and depressed levels of mutated mRNA.
Thrombosis and haemostasis 1996;76(2):143-50.
1996: Jørgen Ingerslev; D Freidman; D Gastineau; G Gilchrist; H Johnsson; G Lucas; J McPherson; E Preston; E Scheibel; Marc Shuman
Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa.
Haemostasis 1996;26 Suppl 1():118-23.
1996: H Mikkola; Vivien C Yee; Martti Syrjälä; R Seitz; R Egbring; P Petrini; Rolf Ljung; Jørgen Ingerslev; David C Teller; Leena Peltonen; Aarno Palotie
Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit.
Blood 1996;87(1):141-51.
1995: Stylianos Antonarakis; Judith P. Rossiter; M Young; J Horst; P de Moerloose; S S Sommer; Rhett P Ketterling; Haig Kazazian ; Claude Négrier; Christine Vinciguerra; Jane Gitschier; Michel Goossens; Emmanuelle Girodon; N Ghanem; F Plassa; Jean-Maurice Lavergne; M Vidaud; J M Costa; Yves Laurian; S W Lin; S R Lin; M C Shen; David Lillicrap; S A Taylor; S Windsor; Sophie Valleix; Khedoudja Nafa; Y Sultan; Marc Delpech; C L Vnencak-Jones; J A Phillips; R C Ljung; E Koumbarelis; AE Gialeraki; Titika Mandalaki; P Vincent Jenkins; P W Collins; K John Pasi; Anne C Goodeve; Ian R Peake; F Eric Preston; Marianne Schwartz; E Scheibel; Jørgen Ingerslev; D N Cooper; D S Millar; V V Kakkar; F Giannelli; J A Naylor; E F Tizzano; Montserrat Baiget; M Domenech; Carme Altisent; J Tusell; M Beneyto; J I Lorenzo; Christine Gaucher; Claudine Mazurier; Kathelijne Peerlinck; Gert Matthijs; J J Cassiman; J Vermylen; Pier Giorgio Mori; M Acquila; Daniela Caprino; H Inaba
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.
Blood 1995;86(6):2206-12.
1995: L R Nielsen; E Scheibel; Jørgen Ingerslev; Marianne Schwartz
Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients.
Thrombosis and haemostasis 1995;73(5):774-8.
1995: C Thomsen; Ole Winther Rasmussen; Jørgen Ingerslev; Kjeld Hermansen
Plasma levels of von Willebrand factor in non-insulin-dependent diabetes mellitus are influenced by dietary monounsaturated fatty acids.
Thrombosis research 1995;77(4):347-56.
1994: O Rasmussen; C Thomsen; Jørgen Ingerslev; K Hermansen
Decrease in von Willebrand factor levels after a high-monounsaturated-fat diet in non-insulin-dependent diabetic subjects.
Metabolism: clinical and experimental 1994;43(11):1406-9.
1994: Jørgen Ingerslev
Safety of plasma derivatives.
Haemostasis 1994;24(5):311-23.
1994: C Helleberg; E Hippe; Jørgen Ingerslev
[Coagulation factor VII--new physiopathological and therapeutic aspects].
Ugeskrift for laeger 1994;156(34):4805-10.
1994: O Jensson; S Stenbjerg Bernvil; S Jónsdóttir; Jørgen Ingerslev
Mild haemophilia A in Iceland: clinical genetic studies of three families with the same mutation.
Journal of internal medicine 1994;235(5):443-50.
1994: Jørgen Ingerslev
Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--antibodies and reactions.
Annals of hematology 1994;68 Suppl 3():S79-80.
1993: Jørgen Ingerslev; J Ingerslev; T Thelle
[Hereditary protein S deficiency and familial thrombosis. A review with description of a Danish family with protein S deficiency].
Ugeskrift for laeger 1993;155(22):1703-7.
1993: U H Eriksen; H Mølgaard; Jørgen Ingerslev; Torsten Toftegaard Nielsen
[Fatal hemostatic complications following erroneous thrombolytic therapy in patients with suspected acute myocardial infarction].
Ugeskrift for laeger 1993;155(18):1392-4.